Proprotein convertase subtilisin/Kexin type-9 (PCSK-9) inhibitors induced liver injury - a retrospective analysis

BACKGROUND: Proprotein convertase subtilisin/Kexin type 9 (PCSK-9) inhibitors induced liver dysfunction in patients with or without previous liver injury, and this is not well discussed in the previous literature. METHODS: A total sample of 202 patients were retrospectively reviewed at the Universit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafar, Yousuf, Sattar, Yasar, Ullah, Waqas, Roomi, Sohaib, Rashid, Mamoon-Ur-, Khan, Muhammad Shayan, Schmidt, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034434/
https://www.ncbi.nlm.nih.gov/pubmed/32128056
http://dx.doi.org/10.1080/20009666.2019.1710952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034434/
https://www.ncbi.nlm.nih.gov/pubmed/32128056
http://dx.doi.org/10.1080/20009666.2019.1710952

Ejemplares similares